Barclays Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $52
Doximity Raised to Overweight From Equal-Weight by Barclays
Barclays Upgrades Doximity(DOCS.US) to Buy Rating, Raises Target Price to $52
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $45
Doximity Is Maintained at Neutral by B of A Securities
Doximity Analyst Ratings
BofA Securities Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $45
Doximity: A Hold Rating Amidst Positive Advertising Spend Survey and Stable Pricing Environment
Evercore ISI Sticks to Their Hold Rating for Doximity (DOCS)
Wells Fargo Maintains Doximity(DOCS.US) With Sell Rating, Maintains Target Price $19
Doximity Sell Rating: User Engagement and Regulatory Risks Impact Growth Outlook
Baird Adjusts Doximity Price Target to $45 From $41, Maintains Outperform Rating
Baird Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $45
Doximity Analyst Ratings
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $43
Canaccord Genuity Maintains Buy on Doximity, Raises Price Target to $40
CCORF Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $40
Doximity's Strategic Growth and Market Expansion Fuel Buy Rating
Doximity Analyst Ratings
JP Morgan Maintains Neutral on Doximity, Raises Price Target to $30